Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryoglobulinemia | 5 | 2009 | 83 | 0.460 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2020 | 942 | 0.380 |
Why?
|
| Tuberculosis | 1 | 2020 | 2012 | 0.280 |
Why?
|
| Hepatitis C | 5 | 2009 | 1597 | 0.180 |
Why?
|
| Weapons | 1 | 2020 | 17 | 0.170 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2020 | 111 | 0.170 |
Why?
|
| Lentinan | 3 | 1989 | 5 | 0.160 |
Why?
|
| Antibodies, Antinuclear | 1 | 2020 | 340 | 0.150 |
Why?
|
| Hepacivirus | 4 | 1999 | 1343 | 0.150 |
Why?
|
| Purpura | 1 | 1997 | 115 | 0.140 |
Why?
|
| GTP Phosphohydrolases | 1 | 2020 | 523 | 0.140 |
Why?
|
| Phagocytosis | 6 | 1991 | 1520 | 0.130 |
Why?
|
| Paraproteinemias | 1 | 2017 | 252 | 0.120 |
Why?
|
| Microfluidics | 1 | 2020 | 651 | 0.120 |
Why?
|
| Macrophages | 10 | 1991 | 5772 | 0.120 |
Why?
|
| Cryoglobulins | 2 | 2009 | 58 | 0.120 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 2014 | 32 | 0.110 |
Why?
|
| Laboratories | 1 | 2017 | 462 | 0.110 |
Why?
|
| Pathology, Clinical | 1 | 2017 | 377 | 0.110 |
Why?
|
| Mannans | 3 | 1989 | 57 | 0.110 |
Why?
|
| Interferon-alpha | 2 | 1994 | 910 | 0.100 |
Why?
|
| Glucans | 1 | 1992 | 71 | 0.100 |
Why?
|
| Brachial Artery | 1 | 2014 | 375 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1761 | 0.100 |
Why?
|
| Polysaccharides | 3 | 1989 | 1016 | 0.100 |
Why?
|
| Vasodilation | 1 | 2014 | 970 | 0.080 |
Why?
|
| Flaviviridae | 2 | 1999 | 9 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2014 | 929 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 1992 | 1243 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3807 | 0.080 |
Why?
|
| Rheumatoid Factor | 3 | 2009 | 183 | 0.070 |
Why?
|
| Galectin 3 | 1 | 2010 | 238 | 0.070 |
Why?
|
| Monocytes | 3 | 1992 | 2595 | 0.070 |
Why?
|
| Neural Tube Defects | 5 | 1988 | 256 | 0.070 |
Why?
|
| Pinocytosis | 2 | 1986 | 64 | 0.070 |
Why?
|
| Receptors, Immunologic | 1 | 1992 | 1415 | 0.070 |
Why?
|
| Hepatitis, Viral, Human | 2 | 1999 | 141 | 0.060 |
Why?
|
| Receptors, LDL | 2 | 1999 | 491 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 1217 | 0.060 |
Why?
|
| RNA, Viral | 4 | 1999 | 2864 | 0.060 |
Why?
|
| Immunoglobulin Idiotypes | 2 | 1995 | 200 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2020 | 7851 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 2817 | 0.050 |
Why?
|
| Amniotic Fluid | 5 | 1988 | 380 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4427 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1992 | 4348 | 0.050 |
Why?
|
| Thioglycolates | 2 | 1991 | 37 | 0.040 |
Why?
|
| Latex | 2 | 1991 | 49 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6942 | 0.040 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 1999 | 46 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2020 | 425 | 0.040 |
Why?
|
| Immunoglobulin M | 2 | 2009 | 1528 | 0.040 |
Why?
|
| Luminescent Measurements | 5 | 1988 | 341 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 1959 | 0.040 |
Why?
|
| Electrophoresis, Capillary | 1 | 2017 | 63 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2017 | 204 | 0.040 |
Why?
|
| Immunoglobulin G | 3 | 2009 | 4528 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 1998 | 1886 | 0.030 |
Why?
|
| Phagocytes | 3 | 1988 | 292 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 1999 | 651 | 0.030 |
Why?
|
| Standard of Care | 1 | 2020 | 567 | 0.030 |
Why?
|
| Humans | 26 | 2020 | 765956 | 0.030 |
Why?
|
| Endocytosis | 1 | 1999 | 950 | 0.030 |
Why?
|
| Cross Reactions | 2 | 1995 | 824 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 1997 | 995 | 0.030 |
Why?
|
| Complement C3b | 2 | 1991 | 95 | 0.030 |
Why?
|
| Hepatitis C, Chronic | 2 | 1999 | 1032 | 0.030 |
Why?
|
| Keratinocytes | 1 | 1997 | 863 | 0.030 |
Why?
|
| Prenatal Diagnosis | 3 | 1988 | 1270 | 0.020 |
Why?
|
| Trypsin | 1 | 1992 | 487 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4562 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 4108 | 0.020 |
Why?
|
| Peritoneal Lavage | 1 | 1991 | 31 | 0.020 |
Why?
|
| Peritoneal Cavity | 2 | 1989 | 133 | 0.020 |
Why?
|
| Autoantigens | 1 | 1995 | 883 | 0.020 |
Why?
|
| Amniocentesis | 3 | 1988 | 116 | 0.020 |
Why?
|
| Liver | 2 | 1998 | 7562 | 0.020 |
Why?
|
| Receptors, Fc | 2 | 1991 | 536 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 1991 | 5881 | 0.020 |
Why?
|
| Limit of Detection | 1 | 2010 | 272 | 0.020 |
Why?
|
| Neutral Red | 2 | 1988 | 9 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1991 | 1770 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1997 | 4137 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 2009 | 239 | 0.020 |
Why?
|
| Neutrophils | 3 | 1986 | 3776 | 0.020 |
Why?
|
| Immune System | 1 | 1993 | 799 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3655 | 0.020 |
Why?
|
| Immunologic Tests | 1 | 1988 | 101 | 0.020 |
Why?
|
| Complement C3 | 1 | 1989 | 424 | 0.020 |
Why?
|
| Zymosan | 1 | 1987 | 128 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 40065 | 0.020 |
Why?
|
| Biopsy | 1 | 1997 | 6763 | 0.020 |
Why?
|
| Microspheres | 1 | 1989 | 773 | 0.020 |
Why?
|
| Heart Failure | 1 | 2010 | 11840 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 1987 | 268 | 0.020 |
Why?
|
| Female | 17 | 2020 | 396101 | 0.020 |
Why?
|
| Factor XIII | 1 | 1985 | 58 | 0.010 |
Why?
|
| Fibrinolysin | 1 | 1985 | 129 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 6493 | 0.010 |
Why?
|
| Phenazines | 1 | 1984 | 53 | 0.010 |
Why?
|
| Mice | 7 | 2010 | 81818 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11022 | 0.010 |
Why?
|
| Skin | 1 | 1997 | 4489 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1998 | 7599 | 0.010 |
Why?
|
| Antigens | 1 | 1988 | 1438 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1986 | 552 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1992 | 10729 | 0.010 |
Why?
|
| Thrombin | 1 | 1985 | 602 | 0.010 |
Why?
|
| Animals | 9 | 2010 | 168759 | 0.010 |
Why?
|
| Aged | 5 | 2020 | 171114 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 1998 | 14652 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1989 | 1930 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 1986 | 995 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 1987 | 6220 | 0.010 |
Why?
|
| Middle Aged | 5 | 2020 | 223004 | 0.010 |
Why?
|
| Male | 8 | 2020 | 363691 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1992 | 18973 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 1998 | 224 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1992 | 12769 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1999 | 1306 | 0.010 |
Why?
|
| alpha-Fetoproteins | 2 | 1988 | 226 | 0.010 |
Why?
|
| Adult | 4 | 2020 | 223038 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1600 | 0.010 |
Why?
|
| Blood | 1 | 1998 | 597 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 59488 | 0.010 |
Why?
|
| Cell Line | 3 | 1999 | 15543 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 29921 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1991 | 20125 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15398 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39194 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1999 | 2199 | 0.010 |
Why?
|
| United States | 1 | 2020 | 72898 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 9249 | 0.010 |
Why?
|
| Virus Replication | 1 | 1999 | 2447 | 0.010 |
Why?
|
| Artifacts | 1 | 1999 | 1893 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 54806 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 6069 | 0.000 |
Why?
|
| Macrophage-1 Antigen | 1 | 1988 | 283 | 0.000 |
Why?
|
| Pregnancy | 5 | 1988 | 30258 | 0.000 |
Why?
|
| Young Adult | 1 | 2014 | 59886 | 0.000 |
Why?
|
| Anencephaly | 1 | 1987 | 20 | 0.000 |
Why?
|
| Esterases | 1 | 1987 | 89 | 0.000 |
Why?
|
| Peroxidases | 1 | 1987 | 134 | 0.000 |
Why?
|
| Opsonin Proteins | 1 | 1986 | 138 | 0.000 |
Why?
|
| Adolescent | 1 | 2014 | 88832 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1987 | 696 | 0.000 |
Why?
|
| Antigens, Differentiation | 1 | 1988 | 919 | 0.000 |
Why?
|
| Receptors, Complement 3b | 1 | 1985 | 124 | 0.000 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1987 | 564 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 2548 | 0.000 |
Why?
|
| Receptors, Complement | 1 | 1985 | 240 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1987 | 1701 | 0.000 |
Why?
|
| Peroxidase | 1 | 1987 | 606 | 0.000 |
Why?
|
| Herpes Simplex | 1 | 1987 | 472 | 0.000 |
Why?
|
| Superoxide Dismutase | 1 | 1985 | 593 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1987 | 1689 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2009 | 81515 | 0.000 |
Why?
|
| Cytomegalovirus Infections | 1 | 1987 | 836 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1984 | 1072 | 0.000 |
Why?
|
| Phenotype | 1 | 1988 | 16721 | 0.000 |
Why?
|
Concepts
(160)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_